http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_082cf6b41d8a070a24bc7177154b62a7
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Swerdlow |
| name | Anthony J Swerdlow Anthony J. Swerdlow |
| given-name | Anthony J Anthony J. |
| organization-name | Authors' Affiliations: 1Dan L. Duncan Cancer Center; 2Department of Pediatrics, Baylor College of Medicine; 3Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; Sections of 4Cancer Genetics and 5Epidemiology, Institute of Cancer Research, Sutton, Surrey; 6Centre for Epidemiology and Biostatistics, University of Leeds, Leeds; and 7Health Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, United Kingdom Division of Genetics and Epidemiology Institute of Cancer Research London UK; Division of Breast Cancer Research The Institute of Cancer Research London UK Section of Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 2Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom.; 41Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom. Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom;; Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom Division of Genetics and Epidemiology and Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom. The Institute of Cancer Research, Division of Genetics and Epidemiology, London, SM2 5NG, UK; The Institute of Cancer Research, Division of Breast Cancer Research, London, SW7 3RP, UK. Sir Richard Doll Building, Institute of Cancer Research, Sutton, United Kingdom; Divisions of Breast Cancer Research and of Genetics and Epidemiology, and the Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom; Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom 136Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.; 137Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom. Divisions of Genetics and Epidemiology (AJS, RC), Breast Cancer Research (AJS) and Radiotherapy (AH), Institute of Cancer Research, Sutton, UK; University of Manchester and Christie NHS Foundation Trust, Manchester, UK (JR); Gastrointestinal Unit, Royal Marsden Hospital, Sutton, UK (DC); Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK (IS); Cancer Research UK Medical Oncology Unit, St. Bartholomew's Hospital, London, UK (TAL); Cancer Centre, Mount Vernon Hospital, Middlesex, UK (PJH); St. James Institute of Oncology, Leeds, UK (DG); Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK (HHL); Bristol Haematology and Oncology Centre, Bristol, UK (SJF); Addenbrooke's Hospital, Cambridge, UK (MVW); Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK (BWH); Guy's and St. Thomas, London, UK (SJH); Department of Haematology, University College Hospital, London, UK (DCL); Southampton General Hospital, Southampton, UK (AB); Queen Elizabeth Hospital, Birmingham, UK (AMS). The England and Wales Hodgkin Lymphoma Follow-up Group includes the authors of this article plus: Gabriel Anghel, Lincoln Hospital; Brian Attock, North Devon District Hospital; Jane Barrett, Royal Berkshire Hospital; Andrew Bell, Poole Hospital; Kim Benstead, Cheltenham General Hospital; Eric M. Bessell, Nottingham University Hospital; Ashoke Biswas, Royal Preston Hospital; Norbert Blesing, Great Western Hospital, Swindon; Caroline Brammer, New Cross Hospital, Wolverhampton; Jill Brock, Clatterbridge Centre for Oncology; Alison Brownell, Queens Hospital, Romford; A. Murray Brunt, University Hospital of North Staffordshire; Peter B. Coates, Queen Elizabeth Hospital, King's Lynn; Matthew P. Collinson, Royal Cornwall Hospital; Neville Davidson, Essex County Hospital; Sian Davies, North Middlesex University Hospital; Ian Fentiman, Guy's Hospital; Eve Gallop-Evans, Velindre Hospital; Angel Garcia, Glan Clwyd Hospital; Andrew Goodman, Royal Devon and Exeter Hospital; Ad 1Section of Epidemiology, Anthony J. Swerdlow, Craig D. Higgins, and Alan Horwich, Institute of Cancer Research; David Cunningham, Royal Marsden Hospital, Sutton; Paul Smith and David C. Linch, University College Hospital; T. Andrew Lister and Ama Z.S. Rohatiner, St Bartholomew's Hospital, London; Barry W. Hancock, Weston Park Hospital, Sheffield; Peter J. Hoskin, Mount Vernon Hospital, Middlesex; and John A. Radford, Christie Hospital and University of Manchester, Manchester, United Kingdom. Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey, U.K Division of Genetics and Epidemiology and,; Division of Breast Cancer Research, Institute of Cancer Research, London, UK, 1Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.; 2Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom. 3Section of Epidemiology, Institute of Cancer Research, Sutton; and The Institute of Cancer Research, London, UK 8Section of Epidemiology, Institute of Cancer Research, Sutton, United Kingdom Division of Genetics and Epidemiology The Institute of Cancer Research London UK; Division of Breast Cancer Research The Institute of Cancer Research London UK 8Section of Epidemiology, Institute of Cancer Research, Surrey, United Kingdom; and Section of Epidemiology, Institute of Cancer Research, Sutton, United Kingdom Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom. [email protected] From the Institute of Cancer Research (S.P.L., A.J.S., Z.Q.), London; Oxford University (L.M.C.), Oxford; the Strathclyde Diabetic Group (S.D.S.), Glasgow; the University of Leicester (A.C.B., J.L.B.), Leicester; the Royal College of Physicians of Edinburgh (A.D.M.), Edinburgh; the Scottish Study Group for the Care of Diabetes in the Young (N.R.W.), Aberdeen; the Poole Hospital NHS Trust (W.G.), Poole; the University of Bristol (E.A.M.G.), Bristol; The Queen’s University (C.C.P.), Belfast; and Guy’s... 22Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.; 23Division of Breast Cancer Research, Institute of Cancer Research, London, United Kingdom. 9Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey, United Kingdom Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom. Division of Breast Cancer Research, Institute of Cancer Research, London, United Kingdom. Anthony J. Swerdlow, Rosie Cooke, and Alan Horwich, Institute of Cancer Research; David Cunningham, Royal Marsden Hospital, Sutton; Andrew Bates, Southampton General Hospital, Southampton; Stephen J. Falk, Bristol Haematology and Oncology Centre, Bristol; Dianne Gilson, St James Institute of Oncology, Leeds; Barry W. Hancock, Weston Park Hospital, Sheffield; Sarah J. Harris, Guy's and St Thomas'; David C. Linch, University College Hospital; T. Andrew Lister, St Bartholomew's Hospital, London; Peter J.... Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom; Division of Breast Cancer Research, The Institute of Cancer Research, London, England Division of Genetics and Epidemiology; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK Section of Epidemiology, Brookes Lawley Building, Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom. [email protected] Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. Division of Genetics and Epidemiology The Institute of Cancer Research London United Kingdom; Division of Breast Cancer Research The Institute of Cancer Research London United Kingdom Division of Genetics and Epidemiology; Division of Breast Cancer Research; Division of Cancer Genetics, The Institute of Cancer Research, London SW7 3RP, UK Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK Institute of Cancer Research, Sutton, United Kingdom Division of Genetics and Epidemiology (M.E.J., M.S., A.J.S.), Sutton SM2 5NG and London SW3 6JB, United Kingdom;; Division of Breast Cancer Research (M.R., E.J.F., M.D., A.A., A.J.S.), Sutton SM2 5NG and London SW3 6JB, United Kingdom; Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK; Division of Breast Cancer Research, The Institute of Cancer Research, London SW7 3RP, UK. Section of Epidemiology, Institute of Cancer Research, Sutton, UK. [email protected] 97Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.; 98Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom. From the Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey; British National Lymphoma Investigation, Cancer Trials Centre, London; Department of Haematology, University College London Medical School, London; Academic Unit of Clinical Oncology, Cancer Research Centre, Weston Park Hospital, Sheffield; Clinical Oncology, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom The Institute of Cancer Research, London, United Kingdom (M.J.S., L.B.W., M.N.B., M.E.J., A.J.S.) |
Incoming Links
Showing number of triples: 1 to 251 of 251.